CanDiag Obtains $461,000 New Funding

  • Feed Type
  • Date
    9/11/2013
  • Company Name
    CanDiag
  • Mailing Address
    9201 University City Boulevard Charlotte, NC 28223 USA
  • Company Description
    CanDiag, Inc. is a University of North Carolina Charlotte (UNCC) spin-off that was incorporated in November 2010. We have a worldwide exclusive license to a patented tumor antibody that has been used to develop a blood test for the early detection of breast cancer.
  • Website
    http://www.candiaginc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $461,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes include payment of salaries and other compensation and benefits. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor

Trending on Xconomy